Technology
Microlabs has always
viewed technology as a way of increasing efficiency. Over the past couple
of years we have tried to keep up with the industry trend. We have done
this by periodically upgrading and updating our instruments and information
infrastructure to be in line with newer industry standards.
Microlabs now uses our Patient Management Information System (PMIS). Our
PMIS is a company-wide database used to manage information on our patients
and associates. This has allowed the access of results, as far back as
half a decade, to be available in less than a minute. The PMIS is also
integrated on a nationwide network of our centers. Healthcare providers
can now access results from anywhere in the island no matter which center
the patient attended.
Microlabs also uses cross-platform hybrid workstations. A cross-platform
hybrid workstation is a workstation instrument that is able to perform
assays from more than one area of clinical diagnostics. The most common
cross-platforms are immunology and clinical chemistry. In Microlabs we
use the Awareness Technologies ChemWell™ Cross-Platform Workstation.
This platform is based on an Open-System. This allows Microlabs to adapt
numerous assays on one instrument. This has allowed us to greatly increase
our testing catalog and at the same time remain competitive.
Microlabs is also able to offer 18 parameter hematology testing. With
our hematology solutions by ABX France®, Microlabs can meet the demand
of even the most demanding hematologist. Our hematology solutions employs
the latest in automated cell counting techniques; providing more accurate
results than ever before. Our hematology solutions also include Automatic
Abnormal Analysis (Triple A). Automatic Abnormal Analysis ensures that
no erronous result will leave our hematology department. This is done
by flagging abnormal results and repeating them on 3 different platforms,
all automated.
